Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAT-354 in uncontrolled asthma
NCT00640016Phase 2Terminated
- Sponsor
- MedImmune
- Start
- Jan 2008
- Primary completion
- Jul 2008
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of tralokinumab in asthma, sponsored by MedImmune. Started Jan 2008; status: terminated.
02
Drugs
tralokinumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00640016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640016.